This webinar provided a high-level overview of the most promising scientific approaches underway to create vaccines, treat COVID-19 symptoms, cure serious cases, and prevent infection. Panelists discussed how the existing R&D pipeline is being leveraged to address COVID-19 and provided examples of public-private partnerships.
Watch the recorded webinar here. (Registration required.)
Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy, Duke University
Stefano Bertuzzi, PhD, MPH, Chief Executive Officer, American Society for Microbiology
Julie Gerberding, MD, MPH, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health, Merck
Resources mentioned in the webinar: